Literature DB >> 8388401

Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy.

M J Carella1, L S Srivastava, V V Gossain, D R Rovner.   

Abstract

"Steroid burst therapy" is commonly used for various acute medical conditions, but its suppressive effect on hypothalamic-pituitary-adrenocortical (HPA) function and the time period for recovery of HPA function is not fully known. We therefore evaluated the HPA function in 10 normal adults before and after a short burst of Prednisone (40 mg/three times daily for 3 days, then tapered over the next 4 days). HPA function was evaluated by iv administration of 100 micrograms of ovine CRH (oCRH) and blood samples for ACTH and cortisol assay were obtained at -30,0,10,15,30,60,90, and 120 min. On another day, 250 micrograms synthetic ACTH (Cosyntropin) were given iv and blood samples for cortisol were obtained at 0,30,60, and 90 min. Basal and peak levels of ACTH and cortisol before and 1,2, and 3 weeks after discontinuation of prednisone in response to oCRH iv are shown below (see Table 1). All values are mean (SEM). Peak levels of cortisol after iv administration of Cosyntropin at week 0 were 922(56.8), week 1 899(63.7), week 2 861(70.9), and week 3 855(53.0). There was no significant difference noted in the levels of ACTH and cortisol in response to oCRH before and after prednisone treatment. Pre- and posttreatment responses of cortisol to Cosyntropin administration were also similar. In addition, cumulative responses (area under the curve) and the change from baseline (delta) before and after administration of prednisone were similar for ACTH and cortisol. We conclude that HPA function is normal 1 week after discontinuation of a short burst of prednisone. These findings suggest that administration of additional steroids may not be required during periods of "stress" for those patients who have previously received similar steroid burst therapy, if at least 1 week has elapsed after such treatment was given.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388401     DOI: 10.1210/jcem.76.5.8388401

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Dexamethasone-related adrenal insufficiency in patients with brain and skull base tumours.

Authors:  H Benghiat; P Sanghera; D Stange; P Nightingale; A Hartley; M W O'Reilly; N Nundall; H Currie; M Ali; G Cruickshank; D Spooner; A Toogood
Journal:  Support Care Cancer       Date:  2018-06-01       Impact factor: 3.603

2.  Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in Rats.

Authors:  Linjing Zhao; Aihua Zhao; Tianlu Chen; Wenlian Chen; Jiajian Liu; Runmin Wei; Jing Su; Xuelan Tang; Keyi Liu; Ran Zhang; Guoxiang Xie; Jun Panee; Mingfeng Qiu; Wei Jia
Journal:  J Proteome Res       Date:  2016-06-20       Impact factor: 4.466

3.  A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients.

Authors:  Hye-Suk Han; Young Kwang Shim; Jeong Eun Kim; Hyun-Jung Jeon; Sung-Nam Lim; Tae-Keun Oh; Ki Hyeong Lee; Seung Taik Kim
Journal:  Support Care Cancer       Date:  2011-08-18       Impact factor: 3.603

Review 4.  [Adrenal cortex and steroids. Supplementary therapy in the perioperative phase].

Authors:  A S Milde; B W Böttiger; M Morcos
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

5.  A comparison of pituitary-adrenal responses to corticotropin-releasing hormone, hypoglycaemia and metyrapone in children with brain tumours and growth hormone deficiency.

Authors:  I Fujiwara; Y Igarashi; E Ogawa
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

6.  Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone.

Authors:  R Collomp; Z Labsy; H Zorgati; F Prieur; F Cottin; M C Do; O Gagey; F Lasne; K Collomp
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

7.  Impact of short-term hydrocortisone intake on pituitary and adrenal function in healthy young male subjects.

Authors:  Katia Collomp; Virgile Amiot; Barbara Robin; Magnus Ericsson; Corinne Buisson
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633

8.  Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis.

Authors:  Kristina Laugesen; Irene Petersen; Henrik Toft Sørensen; Jens Otto Lunde Jørgensen
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

9.  Physiological-dose steroid therapy in sepsis [ISRCTN36253388].

Authors:  Orhan Yildiz; Mehmet Doganay; Bilgehan Aygen; Muhammet Güven; Fahrettin Keleştimur; Ahmet Tutuû
Journal:  Crit Care       Date:  2002-04-19       Impact factor: 9.097

10.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Authors:  Dora Liu; Alexandra Ahmet; Leanne Ward; Preetha Krishnamoorthy; Efrem D Mandelcorn; Richard Leigh; Jacques P Brown; Albert Cohen; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-15       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.